Our laboratory’s interest is in mucosal immunology and the gut microbiota. We mechanistically interrogate the role of microbes and their metabolites in shaping susceptibility and resistance to diseases, including cancer, inflammatory bowel diseases, and kidney diseases.
Research scientist Rachel Grashow, director of epidemiological research initiatives with the Football Players Health Study at Harvard University, comments on the recent cardiac arrest suffered by the Buffalo Bills’ Damar Hamlin, as well as other serious health issues faced by players.
The Harvard Catalyst Biostatistics Program had an eventful year. The Program saw many successes in 2022, in spite of the continued challenges that we face due to COVID-19. Our biostatistician…
The Harvard University Data Science Initiative (HDSI) announced the AWS Impact Computing Project, a collaboration with Amazon Web Services (AWS) aimed at reimagining data science to identify potential solutions for…
Clinicians should pull back on the widespread use of body mass index (BMI) as a metric for assessing people’s health because it can lead to patient distrust and delayed care, say some health experts.
In a recent article in the Harvard Gazette, Tyler VanderWeele, the John L. Loeb and Frances Lehman Loeb Professor of Epidemiology at the Harvard T.H. Chan School of Public Health…
